$12.8
3.53%
Downside
Day's Volatility :5.27%
Upside
1.8%
1.88%
Downside
52 Weeks Volatility :41.5%
Upside
40.38%
Period | Grail Inc | Index (Russel 2000) |
---|---|---|
3 Months | -11.66% | 0.0% |
6 Months | -23.35% | 0.0% |
1 Year | -23.35% | 0.0% |
3 Years | -23.35% | -21.4% |
Market Capitalization | 404.6M |
Book Value | $86.8 |
Earnings Per Share (EPS) | -87.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -689.26% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 109.7M |
Revenue Per Share TTM | 3.53 |
Quarterly Revenue Growth YOY | 42.6% |
Gross Profit TTM | 0.0 |
EBITDA | -659.9M |
Diluted Eps TTM | -87.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Sell
Neutral
Buy
Grail Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Grail Inc | -2.32% | -23.35% | -23.35% | -23.35% | -23.35% |
Idexx Laboratories, Inc. | -0.56% | -7.19% | 8.01% | -23.33% | 75.58% |
Agilent Technologies Inc. | 4.98% | 0.35% | 30.27% | -6.66% | 93.04% |
Thermo Fisher Scientific, Inc. | -3.52% | 3.42% | 20.66% | 2.59% | 107.02% |
Danaher Corp. | -1.12% | 10.55% | 23.66% | -10.77% | 93.32% |
Iqvia Holdings Inc. | -4.58% | -4.83% | 15.18% | -5.73% | 54.57% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Grail Inc | NA | NA | NA | 0.0 | 0.0 | 0.0 | NA | 86.8 |
Idexx Laboratories, Inc. | 47.39 | 47.39 | 5.03 | 10.59 | 0.63 | 0.23 | NA | 19.16 |
Agilent Technologies Inc. | 30.14 | 30.14 | 3.13 | 5.24 | 0.25 | 0.08 | 0.01 | 20.53 |
Thermo Fisher Scientific, Inc. | 37.18 | 37.18 | 2.23 | 21.73 | 0.14 | 0.05 | 0.0 | 124.17 |
Danaher Corp. | 49.73 | 49.73 | 2.67 | 7.59 | 0.08 | 0.04 | 0.0 | 68.92 |
Iqvia Holdings Inc. | 29.57 | 29.57 | 1.15 | 11.2 | 0.23 | 0.05 | NA | 36.83 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Grail Inc | NA | $404.6M | -23.35% | NA | 0.0% |
Idexx Laboratories, Inc. | Buy | $39.3B | 75.58% | 47.39 | 22.34% |
Agilent Technologies Inc. | Buy | $41.7B | 93.04% | 30.14 | 21.75% |
Thermo Fisher Scientific, Inc. | Buy | $228.7B | 107.02% | 37.18 | 14.69% |
Danaher Corp. | Buy | $195.0B | 93.32% | 49.73 | 17.83% |
Iqvia Holdings Inc. | Buy | $41.5B | 54.57% | 29.57 | 9.39% |
Organization | Grail Inc |
Employees | 1360 |
CEO | Mr. Robert P. Ragusa |
Industry | Miscellaneous |
Generations Bancorp Ny Inc
$12.80
-1.77%
Utime Ltd
$12.80
-1.77%
Ncs Multistage Holdings Inc
$12.80
-1.77%
Aam Brentview Dividend Growth Etf
$12.80
-1.77%
Invesco Nasdaq Next Gen 100 Etf
$12.80
-1.77%
Cohen & Steers Tax-advantage
$12.80
-1.77%
Sim Acquisition Corp I-a
$12.80
-1.77%
Victoryshares Westend Global Equity Etf
$12.80
-1.77%
Flotek Industries Inc
$12.80
-1.77%